During the past decade, King Khalid University Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Khalid University Hospital" #1 sponsor was "King Saud University" with 7 trials, followed by "Princess Al-Johara Al-Ibrahim Cancer Research Center" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "King Khalid University Hospital" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Khalid University Hospital" #1 collaborator was "Almarai" with 1 trials as a collaborator, "Clinart International" with 1 trials as a collaborator, "Institut des Maladies Rares" with 1 trials as a collaborator, "John Hopkins Aramco Healthcare" with 1 trials as a collaborator and "King Abdulaziz Medical City" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "King Khalid University Hospital" are "Obesity, Morbid" (2 trials), "Acute Coronary Syndrome" (1 trials), "Alopecia Totalis" (1 trials), "Alopecia Universalis" (1 trials) and "Anal Fistula" (1 trials). Many other conditions were trialed in "King Khalid University Hospital" in a lesser frequency.

Most popular intervention types in "King Khalid University Hospital" are "Drug" (11 trials), "Device" (6 trials), "Procedure" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mitapivat" (2 trials), "Placebo Matching Mitapivat" (2 trials), "Ambu AuraOnce (AO)" (1 trials) and "Amino levulinic Acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Khalid University Hospital" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "King Khalid University Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in King Khalid University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in King Khalid University Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".